ITDD News
A successful first-in-human clinical study of YCT-529, a hormone-free birth control pill for men developed by Dr. Gunda Georg of the College of Pharmacy and YourChoice Therapeutics, demonstrated its safety.
…Prof. Courtney Aldrich and his collaborators recently published an article in Nature Communications on their work with Mycobacterium tuberculosis and biotin synthesis. Their discovery is noteworthy:
"Lipid biosynthesis in the pathogen Mycobacterium tuberculosis …
YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill. The initial preclinical studies, funded in part by the…